Fig. 5From: A comprehensive prognostic and immune analysis of enhancer RNA identifies IGFBP7-AS1 as a novel prognostic biomarker in Uterine Corpus Endometrial CarcinomaTME analysis for IGFBP7-AS1 and IGFBP7. A The IGFBP7-AS1 expression differences in Stromal score, B Immune score, C ESTIMATE score and D Tumor purity. E The IGFBP7 expression differences in Stromal score, F Immune score, G ESTIMATE score and H Tumor purityBack to article page